Outcomes and prognostic factors of immune checkpoint inhibitor resumption in advanced melanoma, results from the MIRROR (melanoma immunotherapy resumption: Retrospective outcomes review) multicenter real-world study

EJC Skin Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles